Trial Profile
A Phase III, Open-Label Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis Catheters
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Jan 2017
Price :
$35
*
At a glance
- Drugs Tenecteplase (Primary)
- Indications Catheter thrombosis
- Focus Therapeutic Use
- Acronyms TROPICS-4
- Sponsors Genentech
- 24 Dec 2009 New trial record.